Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY   US02043Q1076

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/18/2014 07/21/2014 07/22/2014 07/23/2014 07/24/2014 Date
53.82(c) 54.11(c) 55.26(c) 55.86(c) 55.76(c) Last
493 493 436 626 456 377 359 153 399 755 Volume
+3.46% +0.54% +2.13% +1.09% -0.18% Change
More quotes
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which develops novel therapeutics based on RNA interference. It is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including... 
Surperformance© rating of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 40,2 M
EBIT 2014 -269 M
Net income 2014 -331 M
Finance 2014 832 M
Yield 2014 -
Sales 2015 42,1 M
EBIT 2015 -183 M
Net income 2015 -180 M
Finance 2015 610 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 84,0x
EV / Sales 2015 85,6x
Capitalization 4 213 M
More Financials
Latest news on ALNYLAM PHARMACEUTICALS, I
3d ago ALNYLAM PHARMACEUTICALS : Receives Notice of Allowance from United States Patent..
07/11 ALNYLAM PHARMACEUTICALS : Assigned Patent
07/09 ALNYLAM PHARMACEUTICALS : Added to Russell 1000 Index as a Member of the Large-C..
07/09 ALNYLAM PHARMACEUTICALS : Elects Amy Schulman to its Board of Directors
07/07 ALNYLAM PHARMACEUTICALS : to Host "RNAi Roundtable" Webcast Series
07/07 ALNYLAM PHARMACEUTICALS : to Host “RNAi Roundtable” Webcast Series
07/02 ALNYLAM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
07/02 ALNYLAM PHARMACEUTICALS : Elects Amy Schulman to its Board of Directors
06/30 ALNYLAM PHARMACEUTICALS : Added to Russell 1000 Index as a Member of the Large-C..
06/27 FRIDAY'S ETF MOVERS : Fnx, xbi
06/27 ALNYLAM PHARMACEUTICALS : Assigned Patent
06/25 ALNYLAM PHARMACEUTICALS : and The Alpha-1 Project TAP Form Collaboration for Adv..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Alnylam Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Alnylam Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF